Spots Global Cancer Trial Database for lymphoblastic lymphoma

Every month we try and update this database with for lymphoblastic lymphoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma	NCT01451515	Lymphoblastic L...	Prednisone Vincristine Daunorubicin PEG-asparaginas... Erwinia asparag... Doxorubicin Cyclophosphamid... Cytarabine Thioguanine Clofarabine Methotrexate Mercaptopurine Dexamethasone Hydrocortisone Etoposide	- 21 Years	St. Jude Children's Research Hospital
High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma	NCT03178617	Acute Lymphobla... Acute Myeloid L... Lymphoblastic L... Acute Leukemia	Educational Int... Educational Int... Quality-of-Life... Questionnaire A...	5 Years -	City of Hope Medical Center
Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases	NCT00376519	Graft Versus Ho... Leukemia Lymphoma Multiple Myelom... Myelodysplastic... Secondary Myelo...	cyclophosphamid... cyclosporine fludarabine pho... mycophenolate m... Treg cell infus... umbilical cord ... total-body irra...	18 Years - 45 Years	Masonic Cancer Center, University of Minnesota
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy	NCT01643408	Acute Lymphobla... Lymphoblastic L...	asparaginase Er...	1 Year - 30 Years	Jazz Pharmaceuticals
Safety and Tolerability of HSC835 in Patients With Hematological Malignancies	NCT01474681	Acute Myelocyti... Acute Lymphocyt... Chronic Myeloge... Myelodysplastic... Chronic Lymphoc... Marginal Zone L... Follicular Lymp... Large-cell Lymp... Lymphoblastic L... Burkitt's Lymph... High Grade Lymp... Mantle-cell Lym... Lymphoplasmacyt...	HSC835	10 Years - 55 Years	Novartis
Expanded Access to Navitoclax	NCT03592576	Myelofibrosis Acute Lymphocyt... Lymphoblastic L...	Navitoclax Venetoclax	4 Years -	AbbVie
Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders	NCT01177527	Multiple Myelom... Waldenstrom's M... Smoldering Mult... Lymphoblastic L...		18 Years -	Dana-Farber Cancer Institute
Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment	NCT02881086	Acute Lymphobla... Lymphoblastic L...	Rituximab Nelarabine PEG-Asparaginas... Cranial irradia... Imatinib Idarubicin Dexamethasone Cyclophosphamid... Fludarabine Vincristine Mercaptopurine VP16 Daunorubicin (D... Methotrexate Stem cell trans... Cytarabine Vindesine Adriamycin Prednisolone	18 Years - 55 Years	Goethe University
CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT	NCT03810196	Acute Leukemia Acute Myeloid L... Myelodysplastic... Acute Lymphobla... Mixed Lineage L... Lymphoblastic L... Burkitt Lymphom... Juvenile Myelom...	CliniMACS Cell ...	- 25 Years	Children's Hospital of Philadelphia
Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL	NCT03564704	Leukemia Leukemia, Acute Adult Lymphobla... Leukemia, Lymph... Leukemia, T Cel... Adult Acute Lym... Lymphoblastic L... Lymphoblastic L...	Dexamethasone vincristine Cyclophosphamid... Idarubicin Pegaspargase Adriamycin Methotrexate 6-mercaptopurin... Etoposide Cytarabine Bone marrow asp... Intrathecal inj... Radiation thera... NGS allogeneic hema... Flow-MRD FISH Flow immunophen... Karyotyping Chidamide PET-CT scan	14 Years - 55 Years	Nanfang Hospital, Southern Medical University
SARS-CoV-2 Donor-Recipient Immunity Transfer	NCT04666025	Accelerated Pha... Acute Lymphobla... Acute Myeloid L... Chronic Lymphoc... Chronic Phase C... COVID-19 Infect... Hematopoietic a... Hodgkin Lymphom... Lymphoblastic L... Myelodysplastic... Myelofibrosis Myeloproliferat... Non-Hodgkin Lym...	Biospecimen Col... Diagnostic Labo... Electronic Heal... Questionnaire A...	18 Years -	City of Hope Medical Center
Procrit Versus No Procrit in Acute Lymphocytic Leukemia, Lymphoblastic Lymphoma, or Burkitt's Undergoing Induction/Consolidation Chemotherapy	NCT01099202	Leukemia	Procrit (epoeti...	-	M.D. Anderson Cancer Center
L-asparaginase Encapsulated in Red Blood Cells (Eryaspase) for Treatment of Adult Patients With ALL or LBL	NCT01910428	Acute Lymphobla... Lymphoblastic L...	L-asparaginase ...	18 Years -	ERYtech Pharma
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma	NCT06289673	Acute Lymphobla... Lymphoblastic L... Mixed Phenotype...	Dexamethasone Vincristine Daunorubicin Intrathecal tri... Methotrexate Cytarabine	1 Year - 18 Years	St. Jude Children's Research Hospital
Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for Adult Lymphoblastic Lymphoma	NCT00195871	Lymphoblastic L...	Prednisone, vin... hematopoietic s...	18 Years - 59 Years	Centre Henri Becquerel
Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders	NCT00587054	Allogeneic Stem... Leukemia Non-Hodgkins Lymphoblastic L... Myelodysplastic... Paroxysmal Noct...	cytoreductive r...	18 Years - 55 Years	Memorial Sloan Kettering Cancer Center
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma	NCT06289673	Acute Lymphobla... Lymphoblastic L... Mixed Phenotype...	Dexamethasone Vincristine Daunorubicin Intrathecal tri... Methotrexate Cytarabine	1 Year - 18 Years	St. Jude Children's Research Hospital
Hyper-CVAD Treatment in Lymphoblastic Lymphoma	NCT01813344	Lymphoblastic L...		18 Years -	Ajou University School of Medicine
Hyper-CVAD Treatment in Lymphoblastic Lymphoma	NCT01813344	Lymphoblastic L...		18 Years -	Ajou University School of Medicine
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders	NCT03314974	Acute Leukemia Acute Myeloid L... Acute Lymphobla... Lymphoma Chronic Myeloge... Plasma Cell Leu... Myeloproliferat... Myelofibrosis Myelodysplasia Refractory Anem... High Risk Anemi... Chronic Lymphoc... Small Lymphocyt... Marginal Zone B... Follicular Lymp... Lymphoplasmacyt... Mantle-Cell Lym... Prolymphocytic ... Diffuse Large C... Lymphoblastic L... Burkitt Lymphom... High Grade Non-... Multiple Myelom... Juvenile Myelom... Biphenotypic/Un... MRD Positive Le... Natural Killer ... Acquired Bone M...	HSCT with TBI R... HSCT with Non-T...	- 60 Years	Masonic Cancer Center, University of Minnesota
Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL)	NCT03792256	Leukemia, Lymph... Lymphoblastic L... T-cell Lymphoma T-cell Leukemia Recurrent Disea... Acute Leukemia	Palbociclib Cytarabine Methotrexate Hydrocortisone Doxorubicin Prednisolone Vincristine Pegaspargase Hydrocortisone Prednisone	12 Months - 31 Years	Children's Oncology Group
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies	NCT05476770	Hematologic Mal... AML ALL BPDCN MDS Lymphoblastic L... Lymphoma, B-Cel... Lymphoma, T-Cel... Hodgkin Lymphom... Mixed Phenotype... Acute Undiffere...	Tagraxofusp Fludarabine Cytarabine Dexamethasone Vincristine Azacitidine Methotrexate Cytarabine IT Hydrocortisone	1 Year - 21 Years	Therapeutic Advances in Childhood Leukemia Consortium
MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing	NCT05794880	Leukemia Acute Myeloid L... Myelodysplasia Acute Lymphobla... Chronic Myeloge... Chronic Myeloge... Chronic Myeloge... Biphenotypic Ac... Lymphoblastic L... Burkitt Lymphom... Burkitt Leukemi... Lymphoma After ... Other Malignant...	Magnetic-Activa...	0 Years - 25 Years	Medical College of Wisconsin
Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment	NCT02881086	Acute Lymphobla... Lymphoblastic L...	Rituximab Nelarabine PEG-Asparaginas... Cranial irradia... Imatinib Idarubicin Dexamethasone Cyclophosphamid... Fludarabine Vincristine Mercaptopurine VP16 Daunorubicin (D... Methotrexate Stem cell trans... Cytarabine Vindesine Adriamycin Prednisolone	18 Years - 55 Years	Goethe University
CMC-544 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)	NCT01134575	Acute Lymphobla...	CMC-544 (Inotuz... Rituximab	16 Years -	M.D. Anderson Cancer Center
Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma	NCT03328104	Lymphoblastic L... Lymphoblastic L...	Everolimus Nelarabine Cyclophosphamid... Etoposide	2 Years - 29 Years	Emory University
Observational Study of Nelarabine in Children and Young Adults	NCT00866671	Leukaemia, Lymp...	nelarabine	- 21 Years	GlaxoSmithKline
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies	NCT05476770	Hematologic Mal... AML ALL BPDCN MDS Lymphoblastic L... Lymphoma, B-Cel... Lymphoma, T-Cel... Hodgkin Lymphom... Mixed Phenotype... Acute Undiffere...	Tagraxofusp Fludarabine Cytarabine Dexamethasone Vincristine Azacitidine Methotrexate Cytarabine IT Hydrocortisone	1 Year - 21 Years	Therapeutic Advances in Childhood Leukemia Consortium
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders	NCT03314974	Acute Leukemia Acute Myeloid L... Acute Lymphobla... Lymphoma Chronic Myeloge... Plasma Cell Leu... Myeloproliferat... Myelofibrosis Myelodysplasia Refractory Anem... High Risk Anemi... Chronic Lymphoc... Small Lymphocyt... Marginal Zone B... Follicular Lymp... Lymphoplasmacyt... Mantle-Cell Lym... Prolymphocytic ... Diffuse Large C... Lymphoblastic L... Burkitt Lymphom... High Grade Non-... Multiple Myelom... Juvenile Myelom... Biphenotypic/Un... MRD Positive Le... Natural Killer ... Acquired Bone M...	HSCT with TBI R... HSCT with Non-T...	- 60 Years	Masonic Cancer Center, University of Minnesota
Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patients	NCT00949741	Diffuse Large C... Lymphoblastic L... Burkitt's Lymph...		18 Years -	Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie
T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies	NCT01163201	Hematologic Mal... Acute Myeloid L... Acute Lymphocyt... Chronic Myeloge... Anemia, Refract... Chronic Myelopr... Chronic Lymphoc... Small Lymphocyt... Marginal Zone B... Follicular Lymp... Lymphoplasmacyt... Mantle-Cell Lym... Prolymphocytic ... Large Cell Non-... Lymphoblastic L... Burkitt's Lymph... High Grade Non-...	Treg cells CD3+ Teff cells Fludarabine Cyclophosphamid... Total body irra... Umbilical cord ...	18 Years - 55 Years	Masonic Cancer Center, University of Minnesota
Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors	NCT01100658	ALL, Childhood Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphocytic Leu... Lymphocytic Leu... Lymphocytic Leu... Brain Tumors Cancer of the B... Cancer of Brain Malignant Prima... Brain Neoplasms...	Methylphenidate Placebo	8 Years - 17 Years	University of Minnesota
ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors	NCT02938741	Lymphoblastic L...	Anti-human Thym... Placebo	18 Years - 60 Years	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD	NCT02220985	Accelerated Pha... Acute Biphenoty... Acute Leukemia ... Acute Undiffere... Allogeneic Hema... Blast Phase Chr... Blastic Plasmac... Childhood Acute... Childhood Acute... Donor Lymphoblastic L... Myelodysplastic... Myelodysplastic... Myelodysplastic... Recurrent Acute... Recurrent Acute... Recurrent Child... Recurrent Child... Recurrent Chron... Refractory Acut... Refractory Acut... Acute Lymphobla... Acute Myeloid L...	Allogeneic Hema... Cyclophosphamid... Fludarabine Pho... Laboratory Biom... Methotrexate Mycophenolate M... Peripheral Bloo... Peripheral Bloo... Tacrolimus Thiotepa Total-Body Irra...	- 60 Years	Fred Hutchinson Cancer Center
Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant	NCT02506933	Accelerated Pha... Acute Lymphobla... Acute Myeloid L... Chronic Lymphoc... Chronic Phase C... Cytomegaloviral... Hodgkin Lymphom... Lymphadenopathy Lymphoblastic L... Myelodysplastic... Myelofibrosis Myeloproliferat... Non-Hodgkin Lym...	Laboratory Biom... Multi-peptide C... Placebo	18 Years - 75 Years	City of Hope Medical Center
Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults	NCT02535806	Acute Lymphobla... Lymphoblastic L...	Velcade Methotrexate Methotrexate / ... Dexamethasone Mitoxantrone Vincristine Pegaspargase	1 Year - 39 Years	Children's Mercy Hospital Kansas City
Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHL	NCT01101581	Non Hodgkin's L... NHL Aggressive NHL Diffuse Large B...	Veltuzumab and ... 90Y-epratuzumab... veltuzumab	18 Years -	Gilead Sciences
Observational Study of Nelarabine in Children and Young Adults	NCT00866671	Leukaemia, Lymp...	nelarabine	- 21 Years	GlaxoSmithKline
CMC-544 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)	NCT01134575	Acute Lymphobla...	CMC-544 (Inotuz... Rituximab	16 Years -	M.D. Anderson Cancer Center
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies	NCT05476770	Hematologic Mal... AML ALL BPDCN MDS Lymphoblastic L... Lymphoma, B-Cel... Lymphoma, T-Cel... Hodgkin Lymphom... Mixed Phenotype... Acute Undiffere...	Tagraxofusp Fludarabine Cytarabine Dexamethasone Vincristine Azacitidine Methotrexate Cytarabine IT Hydrocortisone	1 Year - 21 Years	Therapeutic Advances in Childhood Leukemia Consortium
MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing	NCT05794880	Leukemia Acute Myeloid L... Myelodysplasia Acute Lymphobla... Chronic Myeloge... Chronic Myeloge... Chronic Myeloge... Biphenotypic Ac... Lymphoblastic L... Burkitt Lymphom... Burkitt Leukemi... Lymphoma After ... Other Malignant...	Magnetic-Activa...	0 Years - 25 Years	Medical College of Wisconsin
T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies	NCT01163201	Hematologic Mal... Acute Myeloid L... Acute Lymphocyt... Chronic Myeloge... Anemia, Refract... Chronic Myelopr... Chronic Lymphoc... Small Lymphocyt... Marginal Zone B... Follicular Lymp... Lymphoplasmacyt... Mantle-Cell Lym... Prolymphocytic ... Large Cell Non-... Lymphoblastic L... Burkitt's Lymph... High Grade Non-...	Treg cells CD3+ Teff cells Fludarabine Cyclophosphamid... Total body irra... Umbilical cord ...	18 Years - 55 Years	Masonic Cancer Center, University of Minnesota
Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHL	NCT01101581	Non Hodgkin's L... NHL Aggressive NHL Diffuse Large B...	Veltuzumab and ... 90Y-epratuzumab... veltuzumab	18 Years -	Gilead Sciences
Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma	NCT02043587	Acute Lymphocyt... Adult Lymphobla...	DNR VCR PEG-asp CTX Prednisone Liposomal AraC MTX LCV AraC Etoposide Dasatinib Rituximab Hydrocortisone	18 Years - 60 Years	University of California, San Diego
A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma	NCT01614197	Lymphoblastic L... Lymphoblastic L... Peripheral T-ce...	Temsirolimus Etoposide Cyclophosphamid... Methotrexate Hydrocortisone Cytarabine	1 Year - 21 Years	Therapeutic Advances in Childhood Leukemia Consortium
A Study of Venetoclax in Combination With Navitoclax and Chemotherapy in Subjects With Relapsed/Refractory Acute Lymphoblastic Leukemia or Relapsed/Refractory Lymphoblastic Lymphoma	NCT03181126	Acute Lymphobla... Lymphoblastic L...	Navitoclax Chemotherapy Venetoclax	4 Years -	AbbVie
Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe)	NCT04942730	Leukemia, Acute... Myeloid Leukemi... Biphenotypic Ac... Lymphoblastic L... Myelodysplastic... Myeloproliferat...	Fludarabine Bendamustine Hy... Busulfan Cyclophosphamid... Mycophenolate M... Tacrolimus 5Mg ...	18 Years - 75 Years	St. Petersburg State Pavlov Medical University
Combination Chemotherapy and Ofatumumab in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma	NCT01363128	Acute Lymphobla... Adult Acute Lym... Burkitt Leukemi... Burkitt Lymphom... CD20 Positive Childhood Acute... Lymphoblastic L...	Cyclophosphamid... Cytarabine Dexamethasone Doxorubicin Hyd... Laboratory Biom... Methotrexate Ofatumumab Vincristine Sul...	-	M.D. Anderson Cancer Center
Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma	NCT01943682	Acute Myeloid L... Acute Lymphobla... Burkitt Lymphom... Diffuse Large C... Gray Zone Lymph... Lymphoblastic L... Anaplastic Larg... Hodgkin Lymphom...	CPX-351	12 Months - 30 Years	Children's Hospital Medical Center, Cincinnati
MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing	NCT05794880	Leukemia Acute Myeloid L... Myelodysplasia Acute Lymphobla... Chronic Myeloge... Chronic Myeloge... Chronic Myeloge... Biphenotypic Ac... Lymphoblastic L... Burkitt Lymphom... Burkitt Leukemi... Lymphoma After ... Other Malignant...	Magnetic-Activa...	0 Years - 25 Years	Medical College of Wisconsin
A Phase 1/2 Study of the Safety and Efficacy of Anti-CD7 Allogeneic CAR-T Cells (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL	NCT04984356	T-cell Acute Ly... Lymphoblastic L...	WU-CART-007	12 Years -	Wugen, Inc.
Acute Lymphoblastic Leukemia Registry at Asan Medical Center	NCT01761682	Leukemia, Acute... Precursor B-Cel... Leukemia, Biphe... Leukemia, Lymph... Lymphoblastic L...	Diagnosed as AL...	15 Years -	Asan Medical Center
Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHL	NCT01101581	Non Hodgkin's L... NHL Aggressive NHL Diffuse Large B...	Veltuzumab and ... 90Y-epratuzumab... veltuzumab	18 Years -	Gilead Sciences
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment	NCT01790152	Hodgkin Lymphom... Leukemia in Rem... Lymphoblastic L... Osteosarcoma Recurrent Leuke... Recurrent Lymph... Recurrent Malig...	Assessment of T... Laboratory Biom... Quality-of-Life... Questionnaire A...	-	Children's Oncology Group
Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma	NCT03328104	Lymphoblastic L... Lymphoblastic L...	Everolimus Nelarabine Cyclophosphamid... Etoposide	2 Years - 29 Years	Emory University
Thiopurine EnhAnced Maintenance Therapy	NCT02912676	Acute Lymphobla... Lymphoblastic L...	Thioguanine (or...	6 Months - 45 Years	Rigshospitalet, Denmark
Study of Prognostic Factors in Adult Lymphoblastic Lymphoma	NCT03571997	Lymphoblastic L...		15 Years -	PETHEMA Foundation
Chronic and Late Effects of Non-Hodgkin's Lymphoma and Its Treatment in Long Term Survivors	NCT00001301	Lymphoma, Non-H...		-	National Institutes of Health Clinical Center (CC)
Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant	NCT02506933	Accelerated Pha... Acute Lymphobla... Acute Myeloid L... Chronic Lymphoc... Chronic Phase C... Cytomegaloviral... Hodgkin Lymphom... Lymphadenopathy Lymphoblastic L... Myelodysplastic... Myelofibrosis Myeloproliferat... Non-Hodgkin Lym...	Laboratory Biom... Multi-peptide C... Placebo	18 Years - 75 Years	City of Hope Medical Center
Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors	NCT01100658	ALL, Childhood Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphocytic Leu... Lymphocytic Leu... Lymphocytic Leu... Brain Tumors Cancer of the B... Cancer of Brain Malignant Prima... Brain Neoplasms...	Methylphenidate Placebo	8 Years - 17 Years	University of Minnesota
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)	NCT02257684	Acute Lymphobla... Lymphoblastic L...	pegcrisantaspas...	1 Year - 21 Years	Jazz Pharmaceuticals
Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders	NCT01177527	Multiple Myelom... Waldenstrom's M... Smoldering Mult... Lymphoblastic L...		18 Years -	Dana-Farber Cancer Institute
Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma	NCT00187122	Lymphoblastic L...	Vincristine Radiation Thera... Daunomycin L-Asparaginase Cytarabine Methotrexate Mercaptopurine Etoposide Cyclophosphamid... Prednisone Dexamethasone	-	St. Jude Children's Research Hospital
Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases	NCT00376519	Graft Versus Ho... Leukemia Lymphoma Multiple Myelom... Myelodysplastic... Secondary Myelo...	cyclophosphamid... cyclosporine fludarabine pho... mycophenolate m... Treg cell infus... umbilical cord ... total-body irra...	18 Years - 45 Years	Masonic Cancer Center, University of Minnesota
High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma	NCT03178617	Acute Lymphobla... Acute Myeloid L... Lymphoblastic L... Acute Leukemia	Educational Int... Educational Int... Quality-of-Life... Questionnaire A...	5 Years -	City of Hope Medical Center
Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma	NCT00187122	Lymphoblastic L...	Vincristine Radiation Thera... Daunomycin L-Asparaginase Cytarabine Methotrexate Mercaptopurine Etoposide Cyclophosphamid... Prednisone Dexamethasone	-	St. Jude Children's Research Hospital
Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation	NCT04060277	Accelerated Pha... Acute Lymphobla... Acute Myeloid L... Chronic Lymphoc... Chronic Phase C... Hematopoietic a... Hodgkin Lymphom... Lymphoblastic L... Myelodysplastic... Myelofibrosis Myeloproliferat... Non-Hodgkin Lym...	Letermovir Multi-peptide C... Placebo Adminis...	18 Years -	City of Hope Medical Center
Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease	NCT00719888	Acute Biphenoty... Acute Lymphobla... Acute Myeloid L... Burkitt Lymphom... Chronic Lymphoc... Chronic Myeloge... Chronic Phase C... Follicular Lymp... Lymphoblastic L... Lymphoplasmacyt... Mantle Cell Lym... Marginal Zone L... Myelodysplastic... Myelofibrosis Non-Hodgkin Lym... Plasma Cell Mye... Prolymphocytic ... Refractory Anem... Small Lymphocyt...	Cyclophosphamid... Cyclosporine Double-Unit Umb... Fludarabine Laboratory Biom... Mycophenolate M... Total-Body Irra... Umbilical Cord ... Thiotepa	6 Months - 45 Years	Fred Hutchinson Cancer Center
Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma	NCT00866749	Lymphoblastic L... Lymphoblastic L...	Daunorubicin Vincristine PEG-asparaginas... Intrathecal Met... Cyclophosphamid... Cytarabine Mercaptopurine Methotrexate Doxorubicin Thioguanine	12 Years - 40 Years	M.D. Anderson Cancer Center
Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults	NCT02535806	Acute Lymphobla... Lymphoblastic L...	Velcade Methotrexate Methotrexate / ... Dexamethasone Mitoxantrone Vincristine Pegaspargase	1 Year - 39 Years	Children's Mercy Hospital Kansas City
A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors	NCT05428176	Acute Leukemia Acute Lymphobla... Acute Myeloid L... Lymphoblastic L...	Best Practice Internet-Based ... Quality-of-Life... Questionnaire A...	6 Years -	City of Hope Medical Center
Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma	NCT02419469	Leukemia Precursor-B Acu... Lymphoblastic L... Lymphoma	Cytarabine Daunorubicin Vincristine Prednisone PEG asparaginas... Ofatumumab Rituximab Methotrexate Cyclophosphamid... Mercaptopurine Doxorubicin Dexamethasone a... Thioguanine	12 Years - 30 Years	M.D. Anderson Cancer Center
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma	NCT05602194	B Acute Lymphob... B Acute Lymphob... B Acute Lymphob... Lymphoblastic L... Mixed Phenotype... T Acute Lymphob...	Biospecimen Col... Calaspargase Pe... Levocarnitine Pegaspargase Quality-of-Life...	15 Years - 40 Years	Children's Oncology Group
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases	NCT01962636	Acute Myeloid L... Acute Lymphocyt... Chronic Myeloge... Plasma Cell Leu... Myelofibrosis Myelodysplasia Chronic Lymphoc... Small Lymphocyt... Marginal Zone B... Follicular Lymp... Lymphoplasmacyt... Mantle-Cell Lym... Prolymphocytic ... Diffuse Large B... Lymphoblastic L... Burkitt's Lymph... Non-Hodgkin Lym... Multiple Myelom...	Fludarabine Cyclophosphamid... Total Body Irra... Cyclosporine A Mycophenylate m... Umbilical cord ...	- 55 Years	Masonic Cancer Center, University of Minnesota
Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma	NCT03328104	Lymphoblastic L... Lymphoblastic L...	Everolimus Nelarabine Cyclophosphamid... Etoposide	2 Years - 29 Years	Emory University
Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for Adult Lymphoblastic Lymphoma	NCT00195871	Lymphoblastic L...	Prednisone, vin... hematopoietic s...	18 Years - 59 Years	Centre Henri Becquerel
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases	NCT01962636	Acute Myeloid L... Acute Lymphocyt... Chronic Myeloge... Plasma Cell Leu... Myelofibrosis Myelodysplasia Chronic Lymphoc... Small Lymphocyt... Marginal Zone B... Follicular Lymp... Lymphoplasmacyt... Mantle-Cell Lym... Prolymphocytic ... Diffuse Large B... Lymphoblastic L... Burkitt's Lymph... Non-Hodgkin Lym... Multiple Myelom...	Fludarabine Cyclophosphamid... Total Body Irra... Cyclosporine A Mycophenylate m... Umbilical cord ...	- 55 Years	Masonic Cancer Center, University of Minnesota
LBL-2016 for Children or Adolescents in China	NCT02845882	Lymphoblastic L...	Prednisone,Vinc... 6-mercaptopurin... Dexamethasone,V... Dexamethasone,V... Dexamethasone, ... Dexamethasone, ... Methotrexate, 6...	12 Months - 18 Years	Children's Cancer Group, China
Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma	NCT02419469	Leukemia Precursor-B Acu... Lymphoblastic L... Lymphoma	Cytarabine Daunorubicin Vincristine Prednisone PEG asparaginas... Ofatumumab Rituximab Methotrexate Cyclophosphamid... Mercaptopurine Doxorubicin Dexamethasone a... Thioguanine	12 Years - 30 Years	M.D. Anderson Cancer Center
Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHL	NCT01101581	Non Hodgkin's L... NHL Aggressive NHL Diffuse Large B...	Veltuzumab and ... 90Y-epratuzumab... veltuzumab	18 Years -	Gilead Sciences

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: